
News
Monoclonal Antibodies Market to Reach US$726.8 Bn by 2033 at 12.9% CAGR | Persistence Market Research
Monoclonal antibodies (mAbs) have revolutionized the treatment of numerous diseases, from cancer to autoimmune disorders, offering precise and targeted therapeutic benefits. The monoclonal antibodies market
